Join us to hear why we continue to be cautiously optimistic that despite coronavirus impacts on market activity and clinical trials, the healthy run in biopharma will continue.
- Context Setting: Overview of 2019
- Where are we now? 2020 Investment Overview
- What's Next? Predictions for Venture Investment.
Date: Wednesday, May 6, 2020
Time: 10:00 am - 11:00 pm PDT (Pacific Time)
Join Info: Dial-in & Web Access Information Provided with Registration
Managing Director, SVB Bank
Jonathan Norris is a managing director of sales origination for Silicon Valley Bank. Norris oversees business development efforts for banking and lending opportunities as well as spearheading strategic relationships with many life science and healthcare venture capital firms. He also helps SVB Capital through sourcing and advising on limited partnership allocations.
In addition, he speaks at major investor and industry conferences and authors widely cited analyses of healthcare venture capital trends. Norris has more than sixteen years of banking experience working with healthcare companies and venture capital firms.
Norris earned a bachelor's degree in business administration from the University of California, Riverside and a juris doctorate from Santa Clara University.
Partner, Teralys Capital
Cedric Bisson has extensive experience across Canada, USA and Europe creating, building and advising businesses in biopharmaceuticals, healthcare and the innovation sector in general. During his career, he has structured and executed over $4 B in transactions in funds and companies, and has been involved in numerous corporate transactions and public listings.
Cedric is currently healthcare and life sciences partner at Teralys Capital, Canada’s largest private innovation-focused investor, financing funds and companies in tech and life sciences, from early stage start-ups to expansion, growth and technology buy-outs. He was previously managing partner at iNovia Capital in Montreal, Calgary and the USA, a private venture capital firm aimed at entrepreneurship and company building. Prior to this, he spent many years internationally at McKinsey & Company, a global management consulting firm, where he was a leader in the biopharma, healthcare and innovation practices in Canada, the US and Europe. Cedric obtained a M.D. degree from McGill University and a J.D. (law) degree from Universite de Montreal. He actively engages globally on impactful innovation and public policy, most notably as board member with Montreal InVivo, a life sciences and health technologies cluster, Grand Challenges Canada, a Toronto organization dedicated to supporting bold ideas with big impact in global health, and other organizations.